Relaxation Response and Resiliency Training and Its Effect on Healthcare Resource Utilization

James E Stahl, Michelle L Dossett, A Scott LaJoie, John W Denninger, Darshan H Mehta, Roberta Goldman, Gregory L Fricchione, Herbert Benson, James E Stahl, Michelle L Dossett, A Scott LaJoie, John W Denninger, Darshan H Mehta, Roberta Goldman, Gregory L Fricchione, Herbert Benson

Abstract

Background: Poor psychological and physical resilience in response to stress drives a great deal of health care utilization. Mind-body interventions can reduce stress and build resiliency. The rationale for this study is therefore to estimate the effect of mind-body interventions on healthcare utilization.

Objective: Estimate the effect of mind body training, specifically, the Relaxation Response Resiliency Program (3RP) on healthcare utilization.

Design: Retrospective controlled cohort observational study.

Setting: Major US Academic Health Network.

Sample: All patients receiving 3RP at the MGH Benson-Henry Institute from 1/12/2006 to 7/1/2014 (n = 4452), controls (n = 13149) followed for a median of 4.2 years (.85-8.4 yrs).

Measurements: Utilization as measured by billable encounters/year (be/yr) stratified by encounter type: clinical, imaging, laboratory and procedural, by class of chief complaint: e.g., Cardiovascular, and by site of care delivery, e.g., Emergency Department. Subgroup analysis by propensity score matched pre-intervention utilization rate.

Results: At one year, total utilization for the intervention group decreased by 43% [53.5 to 30.5 be/yr] (p <0.0001). Clinical encounters decreased by 41.9% [40 to 23.2 be/yr], imaging by 50.3% [11.5 to 5.7 be/yr], lab encounters by 43.5% [9.8 to 5.6], and procedures by 21.4% [2.2 to 1.7 be/yr], all p < 0.01. The intervention group's Emergency department (ED) visits decreased from 3.6 to 1.7/year (p<0.0001) and Hospital and Urgent care visits converged with the controls. Subgroup analysis (identically matched initial utilization rates-Intervention group: high utilizing controls) showed the intervention group significantly reduced utilization relative to the control group by: 18.3% across all functional categories, 24.7% across all site categories and 25.3% across all clinical categories.

Conclusion: Mind body interventions such as 3RP have the potential to substantially reduce healthcare utilization at relatively low cost and thus can serve as key components in any population health and health care delivery system.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. Sample selection.
Fig 1. Sample selection.
Fig 2. Utilization by Functional class: high…
Fig 2. Utilization by Functional class: high utilizing controls vs. propensity score, initial utilization rate matched intervention group.
INT = Intervention, CTL = Control, Clin = Clinical, Imag = Imaging, Lab = Laboratory, Proc = Procedure.
Fig 3. Utilization by Clinical Site: high…
Fig 3. Utilization by Clinical Site: high utilizing controls vs. propensity score, initial utilization rate matched intervention group.
INT = Intervention, CTL = Control, Clin = Clinical, Imag = Imaging, Lab = Laboratory, Proc = Procedure.

References

    1. Dusek J, Chang BH, Zaki J, Lazar S, Deykin A, Stefano GB, et al. (2006) Association between oxygen consumption and nitric oxide production during the relaxation response. Med Sci Monit 12: CR1-10.
    1. Bierhaus A, Humpert P, Nawroth P (2004) NF-κB as a molecular link between psychosocial stress and organ dysfunction. Pediatric Nephrology 19: 1189–1191.
    1. McEwen B (1998) Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 840.
    1. Abraham NG, Brunner EJ, Eriksson JW, Robertson RP (2007) Metabolic syndrome: psychosocial, neuroendocrine, and classical risk factors in type 2 diabetes. Ann N Y Acad Sci 1113: 256–275.
    1. Cohen S, Janicki-Deverts D, Miller G (2007) Psychological stress and disease. JAMA 298.
    1. Esch T, Stefano G, Fricchione G, Benson H (2002) Stress in cardiovascular diseases. Med Sci Monit: RA 93–101.
    1. Esch T, Stefano G, Fricchione G, Benson H (2002) An overview of stress and its impact in immunological diseases. Mod ASP Immunobiol: 187–192.
    1. Esch T, Stefano G, Fricchione G, Benson H (2002) The role of stress in neurodegenerative diseases and mental disorders. Neuroendocrinol Lett: 199–208.
    1. Howland R (1993) General health, health care utilization, and medical comorbidity in dysthymia. Int J Psychiatry Med 23: 211–238.
    1. Katon W, Berg A, Robins A, Risse S (1986) Depression: Patterns of medical utilization and somatization in primary care In In Illness Behaviour: A Multidisciplinary Model. In: McHugh S VT, editor. New York: Plenum; pp. 335–364.
    1. Greenberg P, Stiglin L, Finkelstein S, Berndt E (1993) The economic burden of depression in 1990. Journal of Clnical Psychiatry 54: 405–418.
    1. Lechnyr R (1993) The cost savings of mental health services. EAP Digest 22.
    1. Lane L (1998) Medical cost offset: A review of current research and practices. Preferred Mental Health Management.
    1. Sobel D (2000) The cost-effectiveness of mind-body medicine interventions. Prog Brain Res 122: 393–412.
    1. Herman P, Poindexter B, Witt C, Eisenberg D (2012) Are complementary therapies and integrative care cost-effective? A systematic review of economic evaluations. 2 5.
    1. Wolsko P, Eisenberg D, Davis R, Phillips R (2004) Use of Mind-Body Medical Therapies: Results of a National Survey. J Gen Intern Med 19: 43–50.
    1. Wahbeh H, Haywood A, Kaufman K, Zwickey H (2009) Mind-Body Medicine and Immune System Outcomes: A Systematic Review. Open Complement Med J 1: 25–34.
    1. Park ER, Traeger L, Vranceanu AM, Scult M, Lerner JA, Benson H, et al. (2013) The development of a patient-centered program based on the relaxation response: the Relaxation Response Resiliency Program (3RP). Psychosomatics 54: 165–174. 10.1016/j.psym.2012.09.001
    1. Ludwig D, Kabat-Zinn J (2008) Mindfulness in medicine. JAMA 300: 1350–1352. 10.1001/jama.300.11.1350
    1. Vranceanu A, Gonzalez A, Niles H, Fricchione G, Baim M, Yeung A. (2014) Exploring the effectiveness of a modified comprehensive mind-body intervention for medical and psychologic symptom relief. Psychosomatics 55: 386–391. 10.1016/j.psym.2014.01.005
    1. Caudill M, Schnable R, Zuttermeister P, Benson H, Friedman R (1991) Decreased clinic use by chronic pain patients: response to behavioral medicine intervention. Clin J Pain: 305–310.
    1. Benson H, Rosner B, Marzetta B, Klemchuk H (1974) Decreased blood pressure in pharmacologically treated hypertensive patients who regularly elicited the relaxation response. Lancet: 289–291.
    1. Benson H, Rosner B, Marzetta B, Klemchuk H (1974) Decreased blood pressure in borderline hypertensive subjects who practiced meditation. J Chronic Dis: 163–169.
    1. Dusek J, Hibberd P, Buczynski B, Chang BH, Dusek KC, Johnston JM, et al. (2008) Stress management versus lifestyle modification on systolic hypertension and medication elimination: a randomized trial. Journal of alternative and complementary medicine 14.
    1. Carrington P, Collings GH Jr, Benson H, Robinson H, Wood LW, Lehrer PM, et al. (1980) The use of meditation—relaxation techniques for the management of stress in a working population. J Occup Med: 221–231.
    1. Nakao M, Myers P, Fricchione G, Zuttermeister P, Barsky A, Benson H. (2001) Somatization and symptom reduction through a behavioral medicine intervention a mind/body medicine clinic. Behav Med: 169–176.
    1. Irvin J, Domar A, Clark C, Zuttermeister P, Friedman R (1996) The effects of relaxation response training on menopausal symptoms. J Psychosom Obstet Gynecol: 202–207.
    1. Goodale I, Domar A, Benson H (1990) Alleviation of premenstrual syndrome symptoms with the relaxation response. Obstet Gynecol: 649–655.
    1. Samuelson M, Foret M, Baim M, Lerner J, Fricchione G, Benson H, et al. (2010) Exploring the effectiveness of a comprehensive mind-body intervention for medical symptom relief. J Altern Complement Med 16: 187–192. 10.1089/acm.2009.0142
    1. Fjorback LO, Carstensen T, Arendt M, Ornbol E, Walach H, Rehfeld E, et al. (2013) Mindfulness therapy for somatization disorder and functional somatic syndromes: analysis of economic consequences alongside a randomized trial. J Psychosom Res 74: 41–48. 10.1016/j.jpsychores.2012.09.010
    1. Herron RE (2011) Changes in physician costs among high-cost transcendental meditation practitioners compared with high-cost nonpractitioners over 5 years. Am J Health Promot 26: 56–60. 10.4278/ajhp.100729-ARB-258
    1. Zeng W, Stason WB, Fournier S, Razavi M, Ritter G, Strickler G, et al. (2013) Benefits and costs of intensive lifestyle modification programs for symptomatic coronary disease in Medicare beneficiaries. Am Heart J 165: 785–792. 10.1016/j.ahj.2013.01.018
    1. Carrier E, Reschovsky J, Katz D, Mello M (2013) High physician concern about malpractice risk predicts more aggressive diagnostic testing in office-based practice. Health Aff (Millwood) 32: 1383–1391.
    1. Nakao M, Fricchione G, Myers P, Zuttermeister P, Baim M, Madle CL, et al. (2001) Anxiety is a good indicator for somatic symptom reduction through a behavioral medicine intervention in a mind/body medicine clinic. Psychother Psychosom: 50–57.
    1. Lazar SW, Bush G, Gollub RL, Fricchione GL, Khalsa G, Benson H. (2000) Functional brain mapping of the relaxation response and meditation. Neuroreport 11: 1581–1585.
    1. Chang B, Dusek J, Benson H (2011) Psychobiological changes from relaxation response elicitation: long-term practitioners vs. novices. Psychosomatics 52: 550–559. 10.1016/j.psym.2011.05.001
    1. Black DS, Cole SW, Irwin MR, Breen E, St Cyr NM, Nazarian N, et al. (2013) Yogic meditation reverses NF-kappaB and IRF-related transcriptome dynamics in leukocytes of family dementia caregivers in a randomized controlled trial. Psychoneuroendocrinology 38: 348–355. 10.1016/j.psyneuen.2012.06.011
    1. Seligman M, Csikszentmihalyi M (2000) Positive psychology: an introduction. Am Psychol 55: 5–14.
    1. Wu G, Feder A, Cohen H, Kim J, Calderon S, Charney D, et al. (2013) Understanding resilience. Front Behav Neurosci 7.
    1. Dusek J, Benson H (2009) Mind-Body Medicine: A Model of the Comparative Clinical Impact of the Acute Stress and Relaxation Responses. Minn Med 92: 47–50.
    1. Austin P (2011) An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies. Multivariate Behavioral Research 46: 399–424.
    1. Rubin D (2007) The design versus the analysis of observational studies for causal effects: parallels with the design of randomized trials. Stat Med 26: 20–36.
    1. Austin P (2008) The performance of different propensity-score methods for estimating relative risks. J Clin Epidemiol 61: 537–545. 10.1016/j.jclinepi.2007.07.011
    1. Cummings N, VandenBos G (1981) The twenty years Kaiser-Permanente experience with psychotherapy and medical utilization: implication for national health policy and national health insurance. Health Policy Quarterly 1: 159–175.
    1. Nahin RL, Barnes PM, Stussman BJ, Bloom B (2009) Costs of complementary and alternative medicine (CAM) and frequency of visits to CAM practitioners: United States, 2007. Natl Health Stat Report: 1–14.
    1. van Ravesteijn H, Grutters J, Lucassen P, Bor H, van Weel C, van der Wilt GJ, et al. (2013) Mindfulness-based cognitive therapy for patients with medically unexplained symptoms: A cost-effectiveness study. Journal of Psychosomatic Research 74: 197–205. 10.1016/j.jpsychores.2013.01.001
    1. Clarke TC, Black LI, Stussman BJ, Barnes PM, Nahin RL (2015) Trends in the use of complementary health approaches among adults: United States, 2002–2012. Natl Health Stat Report: 1–16.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit